Clinicopathological and prognostic significance of platelet count in patients with ovarian cancer

References

• Siegel RL, Miller KD, Jemal A. Cancerstatistics, 2017. CA Cancer J Clin 2017;67:7–30
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87–108
   PubMed Web of Science ®Google Scholar
• Berchuck A, Havrilesky LJ, Kauff ND. Is there a role for ovarian cancer screening in high-risk women? J Clin Oncol 2017;35:1384–6
   PubMedGoogle Scholar
• Kim SJ, Rosen B, Fan I, et al. Epidemiologic factors that predict long-term survival following a diagnosis of epithelial ovarian cancer. Br J Cancer 2017;116:964–71
   PubMed Web of Science ®Google Scholar
• Soletormos G, Duffy MJ, Othman Abu Hassan S, et al. Clinical use of cancer biomarkers in epithelial ovarian cancer: updated guidelines from the European Group on Tumor Markers. Int J Gynecol Cancer 2016;26:43–51
   PubMed Web of Science ®Google Scholar
• Kmietowicz Z. Thrombocytosis is linked to increased cancer risk, study finds. BMJ 2017;357:j2481
   Google Scholar
• Buergy D, Wenz F, Groden C, Brockmann MA. Tumor-platelet interaction in solid tumors. Int J Cancer 2012;130:2747–60
   PubMed Web of Science ®Google Scholar
• Su L, Zhang M, Zhang W, Cai C, Hong J. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis. Medicine 2017;96:e6364
   PubMed Web of Science ®Google Scholar
• Josa V, Krzystanek M, Eklund AC, et al. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer. Int J Surg 2015;18:1–6
   PubMed Web of Science ®Google Scholar
• Wang YH, Deng SJ, Yang YD, et al. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Biomarkers Med 2017;11:195–210
   PubMed Web of Science ®Google Scholar
• Long Y, Wang T, Gao Q, Zhou C. Prognostic significance of pretreatment elevated platelet count in patients with colorectal cancer: a meta-analysis. Oncotarget 2016;7:81849–61
   PubMed Web of Science ®Google Scholar
• Pang Q, Qu K, Zhang JY, et al. The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis. Medicine 2015;94:e1431
   PubMed Web of Science ®Google Scholar
• Cheng J, Zeng Z, Ye Q, et al. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis. Oncotarget 2017;8:24327–36
   PubMed Web of Science ®Google Scholar
• Gu L, Li H, Gao Y, et al. The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis. PLoS One 2015;10:e0125538
   PubMed Web of Science ®Google Scholar
• Men H, Liang C, Yu M. Thrombocytosis as a prognostic factor in patients with renal cell carcinoma: a meta-analysis of literature. J Cancer Res Ther 2015;11:67–72
   PubMed Web of Science ®Google Scholar
• Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med 2015;8:5379–87
   PubMed Web of Science ®Google Scholar
• Allensworth SK, Langstraat CL, Martin JR, et al. Evaluating the prognostic significance of preoperative thrombocytosis in epithelial ovarian cancer. Gynecol Oncol 2013;130:499–504
   PubMed Web of Science ®Google Scholar
• Andersen CL, Eskelund CW, Siersma VD, et al. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer? Gynecol Oncol 2015;139:312–18
   PubMed Web of Science ®Google Scholar
• Bottsford-Miller J, Choi HJ, Dalton HJ, et al. Differential platelet levels affect response to taxane-based therapy in ovarian cancer. Clin Cancer Res 2015;21:602–10
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang L, Liu WX, Liu XY. Prognostic significance of preoperative anemia, leukocytosis and thrombocytosis in chinese women with epithelial ovarian cancer. Asian Pac J Cancer Prev 2015;16:933–9
   PubMedGoogle Scholar
• Cozzi GD, Samuel JM, Fromal JT, et al. Thresholds and timing of pre-operative thrombocytosis and ovarian cancer survival: analysis of laboratory measures from electronic medical records. BMC Cancer 2016;16:612
   PubMed Web of Science ®Google Scholar
• Digklia A, Voutsadakis IA. Thrombocytosis as a prognostic marker in stage III and IV serous ovarian cancer. Obstet Gynecol Sci 2014;57:457–63
   PubMedGoogle Scholar
• Eggemann H, Ehricke J, Ignatov T, et al. Platelet count after chemotherapy is a predictor for outcome for ovarian cancer patients. Cancer Invest 2015;33:193–6
   PubMed Web of Science ®Google Scholar
• Feng Z, Wen H, Bi R, Duan Y, Yang W, Wu X. Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients. BMC Cancer 2016;16:43
   PubMed Web of Science ®Google Scholar
• Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L. The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors. Arch Gynecol Obstet 2009;279:53–6
   PubMed Web of Science ®Google Scholar
• Kuyumcuoglu U, Guzel AI, Celik Y, Erdemoglu M. The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor. Eur J Gynaecol Oncol 2010;31:514–16
   PubMed Web of Science ®Google Scholar
• Lee M, Kim SW, Nam EJ, Yim GW, Kim S, Kim YT. The impact of pretreatment thrombocytosis and persistent thrombocytosis after adjuvant chemotherapy in patients with advanced epithelial ovarian cancer. Gynecol Oncol 2011;122:238–41
   PubMed Web of Science ®Google Scholar
• Li AJ, Madden AC, Cass I, Leuchter RS, Lagasse LD, Karlan BY. The prognostic significance of thrombocytosis in epithelial ovarian carcinoma. Gynecol Oncol 2004;92:211–14
   PubMed Web of Science ®Google Scholar
• Ma X, Wang Y, Sheng H, et al. Prognostic significance of thrombocytosis, platelet parameters and aggregation rates in epithelial ovarian cancer. J Obstet Gynaecol Res 2014;40:178–83
   PubMed Web of Science ®Google Scholar
• Man YN, Wang YN, Hao J, et al. Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. Int J Gynecol Cancer 2015;25:24–32
   PubMed Web of Science ®Google Scholar
• Qiu J, Yu Y, Fu Y, Ye F, Xie X, Lu W. Preoperative plasma fibrinogen, platelet count and prognosis in epithelial ovarian cancer. J Obstet Gynaecol Res 2012;38:651–7
   PubMed Web of Science ®Google Scholar
• Soonthornthum T, Suraseraneewong V, Kengsakol K, Wijaithum K, Kasemsan P, Prommatt S. Thrombocytosis in advanced epithelial ovarian cancer. J Med Assoc Thailand 2007;90:1495–500
   PubMedGoogle Scholar
• Stone RL, Nick AM, McNeish IA, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 2012;366:610–18
   PubMed Web of Science ®Google Scholar
• Zeimet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol 1994;170:549–54
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010;25:603–5
   PubMed Web of Science ®Google Scholar
• Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16
   PubMed Web of Science ®Google Scholar
• Kim J, Bae JS. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm 2016;2016:6058147
   PubMed Web of Science ®Google Scholar
• Tesfamariam B. Involvement of platelets in tumor cell metastasis. Pharmacol Ther 2016;157:112–19
   PubMed Web of Science ®Google Scholar
• Li N. Platelets in cancer metastasis: to help the villain to do evil. Int J Cancer 2016;138:2078–87
   PubMed Web of Science ®Google Scholar
• Goubran HA, Stakiw J, Radosevic M, Burnouf T. Platelet-cancer interactions. Semin Thromb Hemost 2014;40:296–305
   PubMed Web of Science ®Google Scholar